These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 23868949

  • 21. The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
    Runia TF, Neuteboom RF, de Groot CJ, de Rijke YB, Hintzen RQ.
    Eur J Neurol; 2015 Mar; 22(3):479-84. PubMed ID: 25430875
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosis.
    Ayuso T, Aznar P, Soriano L, Olaskoaga A, Roldán M, Otano M, Ajuria I, Soriano G, Lacruz F, Mendioroz M.
    PLoS One; 2017 Mar; 12(3):e0174726. PubMed ID: 28355272
    [Abstract] [Full Text] [Related]

  • 24. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
    Runia TF, Hop WC, de Rijke YB, Buljevac D, Hintzen RQ.
    Neurology; 2012 Jul 17; 79(3):261-6. PubMed ID: 22700811
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis.
    Laursen JH, Søndergaard HB, Albrechtsen A, Frikke-Schmidt R, Koch-Henriksen N, Soelberg Sørensen P, Sellebjerg F, Oturai A.
    Mult Scler; 2015 Oct 17; 21(11):1414-22. PubMed ID: 25533295
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.
    Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R.
    J Neuroimmunol; 2009 Feb 15; 207(1-2):117-21. PubMed ID: 19178954
    [Abstract] [Full Text] [Related]

  • 30. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    Pan G, Simpson S, van der Mei I, Charlesworth JC, Lucas R, Ponsonby AL, Zhou Y, Wu F, Taylor BV.
    J Neurol Neurosurg Psychiatry; 2016 Nov 15; 87(11):1204-1211. PubMed ID: 27559181
    [Abstract] [Full Text] [Related]

  • 31. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
    Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I.
    J Neurol Neurosurg Psychiatry; 2008 Feb 15; 79(2):152-7. PubMed ID: 17578859
    [Abstract] [Full Text] [Related]

  • 32. The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)2D3 Induces Super-Enhancers Bound by VDR.
    Lu M, McComish BJ, Burdon KP, Taylor BV, Körner H.
    Front Immunol; 2019 Feb 15; 10():488. PubMed ID: 30941131
    [Abstract] [Full Text] [Related]

  • 33. Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
    Smolders J, Peelen E, Thewissen M, Menheere P, Damoiseaux J, Hupperts R.
    Mult Scler; 2014 Apr 15; 20(4):433-7. PubMed ID: 23959712
    [Abstract] [Full Text] [Related]

  • 34. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis.
    Wang C, Zeng Z, Wang B, Guo S.
    J Nutr Health Aging; 2018 Apr 15; 22(1):38-43. PubMed ID: 29300420
    [Abstract] [Full Text] [Related]

  • 35. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
    Muris AH, Rolf L, Broen K, Hupperts R, Damoiseaux J, Smolders J.
    J Steroid Biochem Mol Biol; 2016 Nov 15; 164():254-257. PubMed ID: 26598277
    [Abstract] [Full Text] [Related]

  • 36. WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
    Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltytė-Benth J, Hovdal H, Myhr KM.
    Acta Neurol Scand; 2016 Apr 15; 133(4):309-12. PubMed ID: 26037530
    [Abstract] [Full Text] [Related]

  • 37. Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.
    Abdollahzadeh R, Fard MS, Rahmani F, Moloudi K, Kalani BS, Azarnezhad A.
    J Neurol Sci; 2016 Aug 15; 367():148-51. PubMed ID: 27423580
    [Abstract] [Full Text] [Related]

  • 38. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep 15; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 39. Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod.
    Ferre' L, Clarelli F, Sferruzza G, Rocca MA, Mascia E, Radaelli M, Sangalli F, Dalla Costa G, Moiola L, Aboulwafa M, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V, Esposito F.
    Neurol Sci; 2018 Aug 15; 39(8):1467-1470. PubMed ID: 29756179
    [Abstract] [Full Text] [Related]

  • 40. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J.
    PLoS Med; 2007 Mar 15; 4(3):e103. PubMed ID: 17388667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.